Breaking News Instant updates and real-time market news.

JPM

JPMorgan

$94.98

0.96 (1.02%)

11:34
08/08/17
08/08
11:34
08/08/17
11:34

Dimon says American tax system has become less competitive over last 20 years

JPMorgan Chairman and CEO Jamie Dimon is being interviewed on CNBC.

  • 12

    Oct

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

JPM JPMorgan
$94.98

0.96 (1.02%)

06/29/17
FBCO
06/29/17
NO CHANGE
Target $102
FBCO
Outperform
JPMorgan price target raised to $102 after CCAR review at Credit Suisse
Factoring in a share repurchase authorization for the 2017 CCAR cycle that she notes was 15% above her forecast and carrying through a higher rate of capital return into 2018, Credit Suisse analyst Susan Roth Katzke raised her price target on JPMorgan shares to $102 from $99 after the bank received Fed approval for its CCAR plan. The analyst keeps an Outperform rating on JPMorgan.
07/06/17
GSCO
07/06/17
INITIATION
Target $93
GSCO
Neutral
JPMorgan initiated with a Neutral at Goldman Sachs
Goldman analyst Richard Ramsden resumed coverage on JPMorgan with a Neutral and a $93 price target saying it is a best-in-class franchise with a premium multiple.
07/06/17
07/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Nike (NKE) initiated with an Outperform at Raymond James. 2. JPMorgan (JPM) initiated with a Neutral at Goldman Sachs. 3. At Home Group (HOME) initiated with a Buy at SunTrust. 4. Logitech (LOGI) initiated with a Buy at Citi. 5. Medtronic (MDT) initiated with an Outperform at William Blair. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/11/17
BARD
07/11/17
NO CHANGE
BARD
Big bank set-up not great, would sell into extended rally, says Baird
Baird analyst David George does not see a great set-up for money-center banks heading into Q2 earnings. He said the trade looks crowded and he would be a seller into an extended rally. George said the risk/reward is less attractive following the sector's most recent rally as economic growth remains muted and the pace of NIM expansion may slow. George believes the biggest potential catalyst would be a gradual steepening of the yield curve and pick-up on loan growth.

TODAY'S FREE FLY STORIES

KOS

Kosmos

$9.45

-0.06 (-0.63%)

14:58
09/24/18
09/24
14:58
09/24/18
14:58
Hot Stocks
Breaking Hot Stocks news story on Kosmos »

First Reserve GP XIII…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$10.76

-0.3 (-2.71%)

14:58
09/24/18
09/24
14:58
09/24/18
14:58
Conference/Events
Switch management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

CGC

Canopy Growth

$52.68

2.92 (5.87%)

, CVSI

CV Sciences

$0.00

(0.00%)

14:55
09/24/18
09/24
14:55
09/24/18
14:55
Hot Stocks
NY Governor signs bill adding pain management as condition for medical marijuana »

New York Governor Andrew…

CGC

Canopy Growth

$52.68

2.92 (5.87%)

CVSI

CV Sciences

$0.00

(0.00%)

ACBFF

Aurora Cannabis

$0.00

(0.00%)

CRON

Cronos Group

$11.80

-0.71 (-5.68%)

TLRY

Tilray

$105.00

-18.155 (-14.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

SBUX

Starbucks

$56.88

-0.52 (-0.91%)

14:50
09/24/18
09/24
14:50
09/24/18
14:50
Periodicals
Starbucks plans 'significant changes' to company structure, Bloomberg says »

Starbucks'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

RRGB

Red Robin

$38.65

-0.55 (-1.40%)

14:50
09/24/18
09/24
14:50
09/24/18
14:50
Conference/Events
Red Robin management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ASNA

Ascena Retail

$3.94

-0.29 (-6.86%)

14:49
09/24/18
09/24
14:49
09/24/18
14:49
Options
Ascena Retail options imply 24.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

AMRN

Amarin

$11.13

8.13 (271.00%)

, SNY

Sanofi

$43.33

-0.28 (-0.64%)

14:48
09/24/18
09/24
14:48
09/24/18
14:48
Hot Stocks
Amarin CEO says Vascepa 'more analogous' to statins than PCSK9 inhibitors »

Amarin CEO John Thero…

AMRN

Amarin

$11.13

8.13 (271.00%)

SNY

Sanofi

$43.33

-0.28 (-0.64%)

REGN

Regeneron

$388.88

-1.67 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 20

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

TRXC

TransEnterix

$6.70

0.27 (4.20%)

14:45
09/24/18
09/24
14:45
09/24/18
14:45
Options
TransEnterix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 27

    Nov

SPPI

Spectrum

$17.18

-4.19 (-19.61%)

14:44
09/24/18
09/24
14:44
09/24/18
14:44
Hot Stocks
Spectrum drops over 20% after releasing poziotinib data from Phase 2 study »

Shares of Spectrum are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

JNJ

Johnson & Johnson

$140.67

-2.18 (-1.53%)

14:43
09/24/18
09/24
14:43
09/24/18
14:43
Periodicals
J&J talc cancer case in California ends in mistrial, Bloomberg reports »

Johnson &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

VSTM

Verastem

$8.98

0.31 (3.58%)

14:39
09/24/18
09/24
14:39
09/24/18
14:39
Hot Stocks
Verastem's Duvelisib approved by FDA »

Duvelisib capsules for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

VSTM

Verastem

$8.98

0.31 (3.58%)

14:38
09/24/18
09/24
14:38
09/24/18
14:38
Hot Stocks
Breaking Hot Stocks news story on Verastem »

Verastem trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

P

Pandora

$9.07

-0.01 (-0.11%)

14:30
09/24/18
09/24
14:30
09/24/18
14:30
Options
Heavy trading in Pandora Monday »

Heavy trading in Pandora…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

GOOG

Alphabet

$1,176.08

9.87 (0.85%)

, GOOGL

Alphabet Class A

$1,183.18

10.96 (0.93%)

14:28
09/24/18
09/24
14:28
09/24/18
14:28
Periodicals
Google to bring Google Lens to Image search results, Engadget says »

According to Engadget,…

GOOG

Alphabet

$1,176.08

9.87 (0.85%)

GOOGL

Alphabet Class A

$1,183.18

10.96 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

VIAB

Viacom

$32.44

0.08 (0.25%)

14:25
09/24/18
09/24
14:25
09/24/18
14:25
Options
Viacom call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
09/24/18
09/24
14:25
09/24/18
14:25
General news
FOMC begins its 2-day meeting Tuesday, with the announcement due Wednesday at 14 ET »

FOMC begins its 2-day…

ESRX

Express Scripts

$94.41

-0.2 (-0.21%)

, GILD

Gilead

$75.68

0.17 (0.23%)

14:20
09/24/18
09/24
14:20
09/24/18
14:20
Hot Stocks
Express Scripts calls Gilead action 'step in the right direction' »

Express Scripts (ESRX)…

ESRX

Express Scripts

$94.41

-0.2 (-0.21%)

GILD

Gilead

$75.68

0.17 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
09/24/18
09/24
14:17
09/24/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
09/24/18
09/24
14:16
09/24/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,177.62

11.41 (0.98%)

, GOOGL

Alphabet Class A

$1,184.38

12.16 (1.04%)

14:13
09/24/18
09/24
14:13
09/24/18
14:13
Hot Stocks
Google launches 'major update' Discover for Search »

Google said in a blog…

GOOG

Alphabet

$1,177.62

11.41 (0.98%)

GOOGL

Alphabet Class A

$1,184.38

12.16 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 03

    Mar

14:10
09/24/18
09/24
14:10
09/24/18
14:10
General news
U.S. equities stabilized above lows after the Rosengren rout »

U.S. equities stabilized…

KORS

Michael Kors

$67.16

-5.51 (-7.58%)

14:09
09/24/18
09/24
14:09
09/24/18
14:09
Recommendations
Michael Kors analyst commentary  »

Versace not seen by many…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$140.70

-2.15 (-1.51%)

, BSX

Boston Scientific

$38.33

0.57 (1.51%)

14:05
09/24/18
09/24
14:05
09/24/18
14:05
Periodicals
J&J may be interested in Boston Scientific, Edwards Lifesciences, Barron's says »

According to an earlier…

JNJ

Johnson & Johnson

$140.70

-2.15 (-1.51%)

BSX

Boston Scientific

$38.33

0.57 (1.51%)

EW

Edwards Lifesciences

$165.13

11.42 (7.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 09

    Oct

  • 16

    Oct

  • 28

    Oct

VKTX

Viking Therapeutics

$18.77

0.555 (3.05%)

14:05
09/24/18
09/24
14:05
09/24/18
14:05
Options
Viking Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

JNJ

Johnson & Johnson

$140.70

-2.15 (-1.51%)

14:02
09/24/18
09/24
14:02
09/24/18
14:02
Periodicals
Breaking Periodicals news story on Johnson & Johnson »

J&J talc cancer case…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.